Literature DB >> 1347644

Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations.

P Gasparini1, A Bonizzato, M Dognini, P F Pignatti.   

Abstract

In this report we describe the use of a DNA amplification technique in which modified primers introduce a base substitution adjacent to the codon of interest and create an artificial restriction site for the detection of mutations which do not produce or modify a naturally occurring restriction site (restriction site generating-polymerase chain reaction, RG-PCR). RG-PCR was developed and applied to the screening in an Italian population sample of several relatively common cystic fibrosis mutations which are not amenable to analysis with a known restriction endonuclease: G542X, 2869insG, Y913C, N1303K, and 1717-1GA. This method, which allows the identification of virtually any single base change by restriction enzyme analysis and without the need for molecular probes, is rapid and easy to perform. The combined use of RG-PCR for several different CF mutations in multiplex tests further expands the advantages of this approach.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347644     DOI: 10.1016/0890-8508(92)90064-5

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  12 in total

1.  Cystic fibrosis genotypes and views on screening are both heterogeneous and population related.

Authors:  C R Scriver; T M Fujiwara
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

2.  Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from north-eastern Italy: identification of 90% of the mutations.

Authors:  A Bonizzato; L Bisceglia; C Marigo; E Nicolis; C Bombieri; C Castellani; G Borgo; L Zelante; G Mastella; G Cabrini
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

3.  CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test.

Authors:  C Castellani; A Bonizzato; G Mastella
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

4.  Cystic fibrosis in Spain: high frequency of mutation G542X in the Mediterranean coastal area.

Authors:  T Casals; V Nunes; A Palacio; J Giménez; A Gaona; N Ibáñez; N Morral; X Estivill
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

5.  Molecular epidemiology of cystic fibrosis mutations and haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure.

Authors:  G Castaldo; E Rippa; G Sebastio; V Raia; P Ercolini; G de Ritis; D Salvatore; F Salvatore
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

6.  Localization of genes for V+LDL plasma cholesterol levels on two diets in the opossum Monodelphis domestica.

Authors:  Candace M Kammerer; David L Rainwater; Nicolas Gouin; Madhuri Jasti; Kory C Douglas; Amy S Dressen; Prasanth Ganta; John L Vandeberg; Paul B Samollow
Journal:  J Lipid Res       Date:  2010-07-22       Impact factor: 5.922

7.  Amino acid substitutions of conserved residues in the carboxyl-terminal domain of the alpha 1(X) chain of type X collagen occur in two unrelated families with metaphyseal chondrodysplasia type Schmid.

Authors:  G A Wallis; B Rash; W A Sweetman; J T Thomas; M Super; G Evans; M E Grant; R P Boot-Handford
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

8.  Scanning the first part of the neurofibromatosis type 1 gene by RNA-SSCP: identification of three novel mutations and of two new polymorphisms.

Authors:  P Gasparini; L D'Agruma; G Pio de Cillis; P Balestrazzi; R Mingarelli; L Zelante
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

9.  Cystic fibrosis in a low-incidence population: two major mutations in Finland.

Authors:  J Kere; X Estivill; M Chillón; N Morral; V Nunes; R Norio; E Savilahti; A de la Chapelle
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

10.  Pancreatic phenotype in infants with cystic fibrosis identified by mutation screening.

Authors:  Marco Cipolli; Carlo Castellani; Bridget Wilcken; John Massie; Karen McKay; Margie Gruca; Anna Tamanini; Maurice Baroukh Assael; Kevin Gaskin
Journal:  Arch Dis Child       Date:  2007-04-20       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.